Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Muscle Invasive Bladder Cancer”
Approved 1
- TremelimumabASTRAZENECA PLCMuscle Invasive Bladder Cancer
Phase 3 2
- Cretostimogene grenadenorepvecCG Oncology, Inc.Non Muscle Invasive Bladder Cancer
- TARA-002Protara Therapeutics, Inc.Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.